Keeping You Informed 23rd June 2025
NHS England has announced that from today Mounjaro and Ozempic is now available from GP services.
Our local NHS Commissioners, Kent & Medway ICB, have advised all practices that we cannot prescribe this at the moment. Therefore, with regret, any requests for these injections will be rejected as we have no control over this.
Please see clinical advice and guidance below and FAQ’s.
Clinical advice and guidance
Access to tirzepatide (Mounjaro) through primary care
As you will be aware, NHS England is making tirzepatide (Mounjaro) available in a phased approached over the next few years. NICE guidelines say that in order to gain access to tirzepatide (Mounjaro) on the NHS, patients must also be referred on to a diet and exercise support programme.
Although it has been announced that it will become available in primary care settings from Monday, 23 June (for a specific patient cohort) arrangements are being made to mobilise a provider of the necessary Behavioural Support for Obesity Prescribing (BSOP) that is specified in the NICE guidelines.
Until this service is in place in Kent and Medway, it is not possible to prescribe tirzepatide (Mounjaro) in primary care.
Please also note there is no provider of tirzepatide (Mounjaro) available under right to choose.
We are aware that this situation may be difficult for practices to explain to patients. If you are approached, NHS England has produced answers to some frequently asked questions for patients.
Patient facing FAQs for tirzepatide (Mounjaro) extracted from NHS (DOCX, 29KB)